Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | SYNJ2 | O15056 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | PPM1B | O75688 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26167583 | 0.85 | LMNA (0.47) | ALDH1A1LMNATDP1POLBMAPK1 | |
| SCHEMBL9604626 | 0.85 | TDP1 (0.43) | ALDH1A1LMNATDP1POLBMAPK1 | |
| SCHEMBL2621420 | 0.85 | LMNA (0.47) | ALDH1A1LMNATDP1POLBMAPK1 | |
| SCHEMBL9604456 | 0.85 | TDP1 (0.43) | ALDH1A1LMNATDP1POLBMAPK1 | |
| SCHEMBL15829785 | 0.85 | TDP1 (0.43) | ALDH1A1LMNATDP1POLBMAPK1 | |
| SCHEMBL9604620 | 0.84 | ALDH1A1 (0.41) | ALDH1A1LMNATDP1POLBMAPK1 | |
| SCHEMBL15829780 | 0.84 | ALDH1A1 (0.41) | ALDH1A1LMNATDP1POLBMAPK1 | |
| SCHEMBL16902759 | 0.84 | ALDH1A1 (0.51) | ALDH1A1LMNATDP1POLBMAPK1 | |
| SCHEMBL18349826 | 0.82 | TDP1 (0.40) | ALDH1A1LMNATDP1POLBMAPK1 | |
| SCHEMBL16902761 | 0.82 | TDP1 (0.40) | ALDH1A1LMNATDP1POLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8772463-B2 | Fluorescent dye-labeled glucose bioprobe, synthesis method and usage thereof | SNU R&DB FOUNDATION (KR) | 2014-07-08 | — | — | US | disclosed |
| US-8632749-B2 | Two photon tracer, method for the preparation thereof and the use thereof in screening anticancer agents | SNU R&DB FOUNDATION (KR) | 2014-01-21 | — | — | US | disclosed |
| US-20110059477-A1 | FLUORESCENT DYE-LABELED GLUCOSE BIOPROBE, SYNTHESIS METHOD AND USAGE THEREOF | SNU R&DB FOUNDATION (KR) | 2011-03-10 | — | — | US | disclosed |
| US-20110059022-A1 | TWO PHOTON TRACER, METHOD FOR THE PREPARATION THEREOF AND THE USE THEREOF IN SCREENING ANTICANCER AGENTS | SNU R&DB FOUNDATION (KR) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059477-A1 | FLUORESCENT DYE-LABELED GLUCOSE BIOPROBE, SYNTHESIS METHOD AND USAGE THEREOF | OGA, UGGT1, GALE | ALDH1A1 85/4885LMNA 3579/4885TDP1 1511/4885 |
| US-20110059022-A1 | TWO PHOTON TRACER, METHOD FOR THE PREPARATION THEREOF AND THE USE THEREOF IN SCREENING ANTICANCER AGENTS | SLC2A2, SLC2A1, SLC2A9 | ALDH1A1 1252/4885LMNA 1629/4885TDP1 2778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.